Detalles de la búsqueda
1.
Characteristics and management of skin cancers in very elderly patients: A real-world challenge for clinicians.
Exp Dermatol
; 31(10): 1554-1562, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35723894
2.
Italian results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer.
Future Oncol
; 17(18): 2315-2324, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33663264
3.
Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis.
Oncologist
; 25(6): e928-e935, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31943506
4.
Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial.
Br J Cancer
; 121(4): 312-317, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31296923
5.
The clinical relevance of multiple DPYD polymorphisms on patients candidate for fluoropyrimidine based-chemotherapy. An Italian case-control study.
Br J Cancer
; 120(8): 834-839, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30858516
6.
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study.
Oncologist
; 24(2): 185-192, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30190299
7.
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
Oncologist
; 24(3): 385-393, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30606884
8.
Blue skin: Intravascular melanoma metastasis detected by means of dermoscopy.
J Eur Acad Dermatol Venereol
; 37(6): e718-e719, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36645856
9.
Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer.
Br J Cancer
; 116(3): 318-323, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28081548
10.
A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma.
Oncologist
; 18(4): 379-80, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23580239
11.
Outcomes in patients with BRAFV600-mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinib.
Tumori
; 109(6): 537-545, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37417313
12.
Prognostic Value of Body Mass Index in Stage II/III Colon Cancer: Posthoc Analysis From the TOSCA Trial.
Clin Colorectal Cancer
; 22(2): 190-198, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36935327
13.
The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study.
Cancers (Basel)
; 15(7)2023 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046641
14.
Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study.
EClinicalMedicine
; 61: 102044, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37434748
15.
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis.
iScience
; 26(11): 107970, 2023 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37860695
16.
Long Term Survival With Regorafenib: REALITY (Real Life in Italy) Trial - A GISCAD Study.
Clin Colorectal Cancer
; 20(4): e253-e262, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34429245
17.
Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy).
Target Oncol
; 16(6): 789-799, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34755244
18.
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial.
Eur J Cancer
; 148: 190-201, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33744715
19.
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trial.
Eur J Cancer
; 148: 422-429, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33812334
20.
Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial.
JAMA Oncol
; 6(4): 547-551, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32053133